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Summary
While it has been known that dendritic cells arise from proliferating precursors in situ, it has
been difficult to identify progenitors in culture. We find that aggregates of growing dendritic
cells develop in cultures of mouse blood that are supplemented with granulocyte/macrophage
colony-stimulating factor (GM-CSF) but not other CSFs. The dendritic cell precursor derives
from the Ia-negative and nonadherent fraction. The aggregates of developing dendritic cells appear
at about 1 wk of culture, with 100 or more such clusters being formed per 106 blood leukocytes.
The aggregates can be dislodged and subcultured as expanding clusters that are covered with
cells having the motile sheet-like processes ("veils") of dendritic cells. By about 2 wk, large
numbers of single, major histocompatibility complex (MHC) class II-rich dendritic cells begin
to be released into the medium. Combined immunoperoxidase and [3H]thymidine autoradiograph}, show that the cells that proliferate within the aggregate lack certain antigenic markers
that are found on mature dendritic cells. However, in pulse-chase protocols, the [3H]thymidinelabeled progeny exhibit many typical dendritic cell features, including abundant MHC class II
and a cytoplasmic granular antigen identified by monodonal antibody 2A1. The progeny dendritic
cells are potent stimulators of the mixed leukocyte reaction and can home to the T-dependent
areas of lymph node after injection into the footpads. We conclude that mouse blood contains
GM-CSF-dependent, proliferating progenitors that give rise to large numbers of dendritic cells
with characteristic morphology, mobility, phenotype, and strong T cell stimulatory function.

he immune system contains a system of dendritic cells
that is specialized to present antigens and initiate several
T
T-dependent immune responses. A good deal is known about
the tissue distribution of dendritic cells (reviewed in reference 1). Dendritic cells are found in nonlymphoid organs either close to body surfaces, as in the skin and airways, or
in interstitial regions of organs like heart and liver. Dendritic
cells, possibly under the control of the cytokine GM-CSF,
can undergo a maturation process that does not entail cell
proliferation (2, 3). Initially, the cells process and present antigens most likely on abundant, newly synthesized MHC class
II molecules, and then strong accessory and cell-cell adhesion functions are acquired (4-7). Dendritic cells can migrate
via the blood and lymph to lymphoid organs (8-10). There,
presumably as the "interdigitating" cells of the T area (8,
11-13), antigens can be presented to T cells in the recirculating
pool (14). However, little is known about the progenitors
of dendritic cells in the different compartments outlined above.
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Dendritic cells in spleen (15) and afferent lymph (16, 17)
are not in cell cycle but arise from a proliferating precursor.
Ultimately, dendritic cells emanate from the bone marrow
(15, 16, 18, 19), yet it has been difficult to generate these
cells in marrow culture, except for two reports describing
their formation in small numbers (20, 21). Here we describe
the formation from mouse blood of proliferating cell aggregates that in turn release large numbers of mature dendritic cells. We will outline this tissue culture system, the
importance of GM-CSF, and the identification of the progeny
as dendritic cells on the basis of cytology, phenotype, and
functional properties.

Materials and Methods
M/c~ We purchasedBALB/c, (BALB/c • DBA/2)F1, (BALB/c
x C57BL/6)Ft, (C57BL/6 • DBA/2)F1, and C57BL/6 males
and females,6-8 wk of age, fromJapan SIC Inc. (Shizuoka,Japan),

J. Exp. Med. 9 The Rockefeller University Press 9 0022-1007/92/05/1157/11 $2.00
Volume 175 May 1992 1157-1167

Downloaded from https://rupress.org/jem/article-pdf/175/5/1157/492443/1157.pdf by Rockefeller University user on 27 July 2020

From the *Department of Zoology, K1/oto University, Sakyo Kyoto 606, Japan; the *Laboratory
of Cellular Physiology and Immunology, The Rockefeller University, New York, New York
10021; the SDepartment of Pathology, Kansai Medical University, Moriguchi, 560 Osaka,
Japan; IIGeneticsInstitute, Cambridge, Massachusetts 02140; and the 82
of
Dermatology, University of Innsbruck, A-6020 Innsbruck, Austria

1158

free medium, and the cultures were separated into nonadherent
released cells and residual adherent aggregates for examination on
cytospin preparations (59900102; Shandon Southern Instruments
Inc.). The cytospun cells were stained for specific antigens with
mAb and immunoperoxidase as above. Also, the slides were dipped
in photographic emulsion (Kodak autoradiography emulsion type
NTB2 #165-4433) for exposure (5 d) before development, staining
with Giemsa, and mounting in Permount. For pulse-chase experiments, a lower dose of [3H]TdR was used to maintain cell viability, but the cells were handled similarly otherwise. The pulse
was applied at 0.1/~Ci/ml for 2 or 16 h, the latter to provide higher
initial labeling indices. The cells were washed and chased for 1-3 d
before harvesting, and analysis was as above with immunoperoxidase, autoradiography, and Giemsa staining.
Mixed Leukocyte Reactions. Cells from the blood cultures were
exposed to 1,500 tad ('TCs) and applied in graded doses to 3 x
105 purified syngeneic or allogeneic T cells in 96-well, flatbottomed microtest wells. The T cells were nylon wool-nonadherent spleen and lymph node suspensions that were treated with
anti-Ia plus Jlld mAbs and complement to remove residual APC.
[3H]TdR uptake was measured at 72-86 h (6 Ci/mM, 4/~Ci/ml
final).
Dendritic Cell Homing. Dendritic cells or other cell types were
labeled at 2-10 x l&/ml with carboxyfluorescein for 10 min on
ice (C-1157; Molecular Probes, Eugene, OK) (30 #M final concentration in HBSS with 5% FCS), washed in RPMI 1640, and injected in a volume of 50/~1 RPMI 1640 into the foot pads. 1 d
later, the draining popliteal lymph nodes were removed, frozen in
OCT medium, and sectioned (10/~M) in a cryostat. To sample
the entire node, we took duplicate specimens at regular intervals.
The sections were applied to multiwell slides (111006; Carlson
Scientific, Peotone, IL), stored at -20~ dried in a dessicator 30
rain before use (or left at room temperature overnight), fixed in
acetone, and stained with a pernxidase-conjugated rabbit anti-FITC
antibody (P404; Dakopatts, Carpinteria, CA). To verify that the
dendritic cells in the lymph node were in the T-dependent areas
as described (8), we added appropriate mAbs to B cells, T cells,
macrophages, or dendritic cells, and visualized the latter with alkaline phosphatase-conjugated mouse anti-rat Ig (605-5357;
Boehringer Mannheim Biochemicals) plus a chromogen kit (S04;
Biomeda Corp., Foster City, CA). We then blocked endogenous
peroxidase with "Endo Blocker" (M69; Biomeda Corp.) followed
by the peroxidase anti-FITC as above.

Results
W h e n mouse blood leukocytes were cultured in GM-CSF
at 30 U/ml, the cultures developed a large number of aggregates from which typical dendritic cells were eventually
released. In the absence of GM-CSF, no colonies developed.
Initially, we used cytologic criteria to detect the dendritic
cells that characteristically extend large, sheet-like processes
or veils (25-27). The procedure for expanding the aggregates
of developing dendritic cells is described first (Fig. 1). Then,
we will consider the phenotype and functional data that identify the progeny as typical mature dendritic cells.

Aggregates of Proliferating Dendritic Cells in Blood Supplemented
with GM-CSE Blood leukocytes, usually from (C x D2)F1
mice, were cultured in 16-ram tissue culture weUs in medium
supplemented with GM-CSF at 30 U / m l and at 1.5 x 106
cells/well. After overnight culture, many monocytes adhered
and the nonadherent cells were transferred to new 16-mm
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the Trudeau Institute (Saranac Lake, NY), and Charles River Wiga
(Sulzberg, FRG).
Blood. Blood was obtained by cardiac puncture or from the
carotid artery. The blood was diluted in, or allowed to drip into,
R.PMI 1640 with 100 U/m1 heparin (~2 ml/mouse). Blood cells
were pelleted at 1,000 rpm at 4~ resuspended in RPMI 1640,
and sedimented again. The pellet was suspended in 1 ml RPMI
1640 per mouse and mixed with an equal volume of 1.66% ammonium chloride in distilled water to lyse the red cells. After 2 min
at room temperature, the suspension was spun at 1,000 rpm at 4~
The pellet, which still contained red cells, was resuspended again
in 0.5 ml RPMI and 0.5 ml NH4C1 for 2 rain, diluted in RPMI,
and sedimented again. After two more washes, most platelets and
red cells had been depleted.
Blood Cultures. The cells were cultured in 24-well dishes (25820;
Costar, Cambridge, MA)in I ml of medium per well. The medium
was RPMI 1640 supplemented with 5% FCS (JRH Biosciences,
Lenexa, KA), 50/~M 2-ME, 20/~g/ml gentamicin, and recombinant
mouse (r)GM-CSF. Four preparations of rGM-CSF were evaluated
with similar results, the yield of dendritic cells reaching a plateau
with 30-100 U/ml. The preparations were from Dr. S. Gillis (Immunex Corp., Seattle, WA); Genetics Institute (supernatant from
COS cells transfected with mGM-CSF; used at 30 U/ml or greater);
and Dr. T. Sudo (supernatant from CHO cells transfected with
the expression vector, pHSmGM-CSF [22]), and Escherichiacoli-expressed material). The protocol is described in detail in Results.
Cultures were fed first at day 6-7, and then every 3 d by aspirating
0.5-0.75 ml of the medium and adding back an equal volume of
fresh medium with GM-CSF. To subculture the wells, we dislodged
by pipetting most of the aggregates of growing dendritic cells as
well as some cells in the monolayer of growing macrophages and
fibroblasts. Pipetting usually disrupted the aggregate, particularly
the peripheral cells that were more mature. With time in culture,
e.g., at 2 wk, the aggregates of the growing dendritic cells became
more stable and it was possible to dislodge the aggregates for separation by 1-g sedimentation. Typically, we applied the contents of
five wells to a 6-ml column of 50% FCS-RPMI 1640 in a 15-ml
conical tube (62.553.002 PS; Sarstedt, Inc., Princeton, NJ). After
at least 20 min, the applied medium and top 1 ml of the column
were removed. RPMI was added, the aggregates were pelleted at
1,000 rpm at 4~ for 5 min, and the cells were suspended gently
for subculture in fresh medium.
Phenotyping with mAbs. A panel ofmAbs was used to identify
and characterize the cells in the GM-CSF-expanded blood cultures.
The mAbs are reviewed elsewhere (23, 24) and are cited in Results.
Cytospin preparations were made in a cytocentrifuge (Shandon
Southern Instruments Inc., Sewickley, PA) using 3-10 x 104 cells.
The slides were stored with dessicant before fixation in acetone
and staining with mAbs followed by peroxidase mouse anti-rat
Ig (605-545; Boehringer Mannheim Biochemicals, Indianapolis, IN)
or rabbit anti-hamster Ig (JZY-036-003; Accurate Chemical &
Scientific Corp., Westbury, NY). The preparations were stained
with Giemsa and mounted in Permount for bright field analysis.
For cytofluorography (FACScan| Becton Dickinson & Co., Mountain View, CA) aliquots of cells were stained with primary rat or
hamster mAb followed by FITC mouse anti-rat Ig (605-540;
Boehringer Mannheim Biochemicals) or biotin rabbit anti-hamster Ig (JZY-066-003; Accurate Chemical & Scientific Corp.) and
FITC-avidin.
Autoradiography. Cultures were labeled with [3H]TdR to identify and phenotype the proliferating cells and their progeny. For
pulse labeling, [3H]TdR. was added to the cultures (6 Ci/mM, 1
#Ci/ml final). 2 h later, the medium was replaced with [3H]TdR.

BLOOD LEUKOCYTES IN GM-CSF
Culture ld to adhere most monocytes
Culture nonadherent cells 6d
Feed with GM-CSF, culture 3d
Rinse loose cells away
AGGREGATES AFFIXED TO A DENSE ADHERENT MONOLAYER
Dislodge aggregates with Pasteur pipettes
Subculture one well to three in GM-CSF
Culture 4-10d feeding q 3d
DENDRITIC CELL AGGREGATES AFFIXED TO SCATTERED ADHERENT CELLS
Subculture as above at 2-3 weeks

Figure 1. Flow plan for inducing dendritic cell
AGGREGATES ATTACHED TO A FEW ADHERENT CELLS PLUS RELEASED DENDRITIC CELLS

adhered as single cells to the new cuhure well, but over a
period of 2-3 d, aggregates reappeared. The aggregates again
were affixed to adherent stromal cells, but these adherent cells
were much less numerous than the dense monolayer in the
original culture. Over the next 4-7 d, aggregates filled the
wells (Fig. 2 A). These colonies were often larger than those
of the original wells and were covered with many sheet-like
processes typical of dendritic cells. It was more difficult to
count cells at this point, since many of the aggregates contained a core of tightly associated cells. However, the number
of single cells that could be recoveredper well expanded about
twofold between days 10 and 17 of culture.
If the cultures were allowed to overgrow, some cells with
the morphology of dendritic cells were released. More typically, we did not allow the cells to overgrow but instead dislodged the aggregates and subcuhured them again at ,,o20 d.
Before subculture, the aggregates could be purified from free

F i g u r e 2. Phase contrast micrographs of dendritic cells developing in vitro. (A) Low power view of a monolayer covered with aggregates of proliferating dendritic cell progenitors (day 17 culture) (• 100). (B) Higher power view of typical dendritic cells (arrows) released from the aggregates (• 400).
1159
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wells. The adherent cells did not develop dendritic cell colonies, but during the next week, the nonadherent populations
exhibited three changes. First, most of the lymphocytes and
granulocytes died or could be removed by washing. Second,
the surface of the well became covered with a monolayer of
tightly adherent cells that included macrophages and fibroblasts. Third, affixed to scattered sites on the monolayer, there
developed small aggregates of cells. The cultures were fed
with GM-CSF at day 6-7. The aggregates continued to expand in number and size. At about day 10, the cells were
ready to be subcuhured. Any residual loose cells could be
rinsed offbefore dislodging the aggregates into fresh medium
and GM-CSF. About 0.8-1 x 106 dislodged cells per
original well were divided into three subculture wells.
Most of the aggregates disassembled during this first subculture, while the bulk of the adherent monolayer remained
attached to the original well. Upon transfer, most of the cells

"colonies."
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Figure 3. Immunoperoxidase labeling of a culture transferred after 2-3 wk to show some of the typical phenotypic features of released dendritic
cell progeny. The primary antibodies are B21-2anti-MHC class II (AmericanTypeCulture Collection [ATCC] TIB 229); M1/69 anti-heat-stable antigen
(HSA, ATCC TIB 125); F4/80 antimacrophage (MAC, ATCC HB 198); NLDC 145 (13) anti-interdigitating cell (IDC, kindly provided by Dr. G.
Kraal, Free University, Amsterdam); RB6 antigranulocyte (an example of a rare granulocyte is shown; GRAN); and 2A1, a mAb that reacts primarily
with granuleswithin the cytoplasmof cultured dendriticcellsin vitro, and interdigitatingceUsin situ (Witmer-Packet al., manuscriptin preparation)(x 600).

cells by 1-g sedimentation. Such separations were more easily
performed with longer periods of culture; i.e., it was easier
to isolate intact aggregates at 3 vs. 2 vs. 1 wk of culture.
With additional subculturing, the number of aggregates that
were produced per well was progressively reduced. However,
1160

colonies of growing cells, as confirmed by [3H]TdR labeling
and autoradiography (see below), could be generated in subcultures for 1-2 mo.
After subculturing at 2-3 wk, typical single dendritic cells
were now released into the medium (Fig. 2 B). By direct ob-
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FACS| analyses of dendritic cells released from proliferating
aggregates. Several mAbs summarized elsewhere (23, 24, 28) are shown.
Except for MHC class I and II products, the phenotype of the released
cells is homogeneous. Staining with no primary mAb was identical to
RB6 and RA3.

servation with video recording, these released cells had the
active motility of dendritic cells, continually extending and
retracting large veils or sheet-like processes. In the presence
of continued GM-CSF, we observed both free dendritic cells
as well as expanding colonies. In the absence of GM-CSF,
only free dendritic cells were released into the medium. The
aggregates essentially fell apart and did not reform. The yields
of free dendritic ceils per subculture ranged from 0.3 to 2.5
x lOs.
In summary, from a starting blood mononuclear culture
of 1.5 x 106 cells, where dendritic cells were difficult to detect, we on average obtained 5-10 subcultures each with at
least 3-10 x 104 released dendritic cells at 3 wk, as well as
many aggregates capable of further proliferation. Therefore,
aggregates of growing cells were developing in mouse blood
supplemented with GM-CSF, and these aggregates were covered with dendritic cells, many of which could be released
spontaneously into the medium.

Phenotype of the Cell Aggregates and Dendritic Cells Released
Therefrom. Cytospin preparations of 2-3-wk cultures were
examined with a panel of mAbs and an immunoperoxidase
method. The released cells, and many of the cells that could
be dislodged from the periphery of the aggregate, were similar
in their stellate shape and phenotype (Fig. 3). Most of the
cells stained strongly with mAb to MHC class II (Fig. 3),
the CD45 leukocyte common antigen, CR3 receptor CD11b,
heat-stable antigen (HSA; Fig. 3), and CD44. Staining with
1161
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[3H]TdR Autoradiography to Verify Growth of Dendritic Cell
Precursors. After 2 and 3 wk in liquid culture, the wells con-

Downloaded from https://rupress.org/jem/article-pdf/175/5/1157/492443/1157.pdf by Rockefeller University user on 27 July 2020

'1

mAbs to the Fc receptor (2.4G2) and macrophage F4/80 antigen (MAC; Fig. 3) was weak or undetectable in >95% of
the cells. The cultures contained only rare B cells (B220 mAb,
RA-3), T cells (Thy-1 mAb, B5-5), or granulocytes (GRAN,
mAb RB6; Fig. 3). Some cells at the periphery of the aggregate, and many of the cells that were released from the aggregates, were stained with two markers that are largely restricted to dendritic cells. The interdigitating cell antigen (mAb
NLDC 145 [D], IDC; Fig. 3), which also binds to thymic
epithelium, stained many but not all of the dendritic profiles.
Virtually all of the dendritic profiles stained with mAbs 2A1
(Fig. 3) and M342 (Witmer-Pack et al., manuscript in preparation), which stain granules in the perinuclear region of mature dendritic cells as well as interdigitating cells in sections
through the T areas of lymphoid organs. Macrophages from
many sites (blood monocytes; peritoneal cavity macrophages;
macrophages in sections of lymph node, thymus, spleen) do
not contain 2A1- or M342-reactive granules.
Cytofluorography was used to gain semiquantitative information on the expression of antigens at the cell surface.
A panel of mAbs were applied to two populations: cells that
could be dislodged from the aggregates by Pasteur pipetting,
and cells that were released spontaneously when the aggregates
were subcultured for 1 d. These "dislodged" and "released"
populations were identical in their dendritic shape and in
phenotype, but for some exceptions that are considered below.
The phenotype of the released cells is shown in Fig. 4, and
the few differences between aggregated and released cells are
in Fig. 5. Virtually all the dendritic cells developing in and
from the aggregates expressed high levels of the leukocyte
common (CD45, mAb M1/9.3) and heat-stable (mAbs M1/69
and Jlld) antigens, as well as high levels of CD44 (not shown)
and CD11b (mAb M1/70). Low levels of the following antigens were detected on the cell surface: the dendritic cell
antigen 33D1, the macrophage marker F4/80, the Fc3, receptor
antigen 2.4G2, the p55 IL2 receptor CD25 antigen 3C7,
and the CD11c integrin N418 (Fig. 4). These antigens were
noted on all cells by FACS| even though many of the antigens like F4/80 and 2.4G2 were weak or absent in the
cytoplasm with an immunoperoxidase method (Fig. 3, see
above). Several antigens were absent: RB6 granulocyte, RA3
B cell, B5-5 Thy-1, GK 1.5 CD4, and SER-4 marginal zone
macrophage (Fig. 4).
Expression of class I and II MHC products by the dendritic cells in these cultures was very high but nonetheless
bimodal (Figs. 4 and 5). Most of the dendritic cells that were
dislodged from the aggregates had somewhat lower levels of
MHC class I and II, while dendritic cells that were released
from the aggregates had very high levels of MHC products.
The other marker that was different in the released and loosely
attached dendritic cells was NLDC 145, which was higher
in the released population (Fig. 5, top). We conclude that
the phenotype of the cells that arise from the proliferating
aggregates is very much like that seen in cultured dendritic
cells from skin, spleen, and thymus (24, 28), with the exception that the M1/70 CDllb marker is more abundant.
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Figure 5. FACS| analyses of dendritic cells that could be dislodged by Pasteur pipetting of proliferating aggregates, and dendritic cells released spontaneously in culture. The mAbs are M1/42 anti-MHC class I (ATCC TIB 126); NLDC145 anti-interdigitating cell (13); M5/114 anti-MHC class II
(ATCC TIB 120); 33D1 anti-dendritic cell (ATCC TIB 227); B5-5 anti-Thy-1. The staining with anti-MHC mAbs is bimodal, but the released cell
fraction of dendritic cells is richest in expression of MHC class I and II.
tained numerous expanding aggregates of cells (as in Fig. 2
A), and in some cases were already releasing nonadherent
dendritic cells in large numbers (Fig. 2 B). These cultures
were exposed to [3H]TdR and examined for proliferative activity. T h e labeled cells were washed, spun onto slides, and

the cytospins stained with m A b s and an immunoperoxidase
m e t h o d before dipping and exposure to photographic emulsion. I m p o r t a n t markers were m A b s 2A1 and N L D C - 1 4 5 ,
which recognize intracellular granules and a cell surface antigen in mature dendritic cells, respectively (Fig. 3, see above).

Figure 6. [3H]TdR pulse and pulse-chase labeling of proliferating dendritic cell aggregates and their progeny, respectively. (Left and Middle) Pulse
labeling of aggregates (1 #Ci/ml for 2 h) at ~2 wk of culture. Before dipping in photographic emulsion, the cytospins were stained with an immunoperoxidase method to identify the 2A1 anti-dendritic cell granule antigen (/eft) or the NLDC145 interdigitating cell antigen (middle). The cells
that label for these antigens (black arrows) are not in S phase (white arrows). (Right) Pulse-chase label (0.2 #Ci/ml for 16 h, chase for 2 d) of aggregates
that were isolated by velocity sedimentation and returned to culture to form large numbers of released progeny. In contrast to the left panel, the [3H]TdRlabeled cells express the 2A1 granule antigen characteristic of mature dendritic cells (black arrows), x 425.
1162
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Figure 7. MLK-stimulatingactivityof populations isolated from the
GM-CSF-stimulatedmouseblood cultures (see text).

When cultures were labeled with a 2-h pulse of [3H]TdR.,
it was apparent that the labeling index in the aggregates was
very high, at least 10-15 % of the profiles in the aggregates
being in S phase (Fig. 6, left and middle). In contrast, if
[3H]TdR was applied to cultures that were releasing typical
nonadherent dendritic cells, the released fraction contained
only rare labeled profiles (not shown). If GM-CSF was removed, [3H]TdR labeling ceased within 1 d. Virtually all the
[3H]TdR-labeled cells in the aggregate failed to label with
mAbs to markers found on mature dendritic cells, i.e., 2A1
and NLDC145 (Fig. 6). The level of staining with anti-MHC
class II mAb was less on the cells in S phase than in the released
dendritic cell populations (not shown).
Pulse-chase experiments were then done to establish that
labeled cells in the aggregate were giving rise to typical dendritic cells. Cultures were first exposed to a low dose of
[3H]TdR, either for 2 or 16 h, the latter to label a larger per1163
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MLR-stimulating activity was monitored in the GM-CSFtreated blood cultures. Initially, there was little or no MLRstimulating activity (Fig. 7, ~'). Some stimulating activity
was noted at day 1 of culture (Fig. 7, O). An examination
of cytospin preparations revealed that these 1-d nonadherent
blood cells had a low (<0.3%) but clear subset of Ia-rich,
dendritic profiles. By day 7, when the proliferating aggregates
were first evident on the monolayer, the stimulating activity
of the dislodged aggregates had increased further, but was
still 100 times less in specific activity than typical dendritic
cells (Fig. 7, compare A and e), even though most of the
cells at day 7 and subsequent time points were MHC class
II positive. By day 14, at which time typical nonadherent
dendritic cells were just beginning to be released from the
aggregates, the nonadherent population had considerable
MLR-stimulating activity (Fig. 7, V). After 3 wk, typical
mature dendritic cells had become abundant, and these indeed stimulated comparably to their splenic counterparts (Fig.
7, compare <> and e). Other cells in the culture, such as
those dislodged from the aggregates, were "+10-fold less active than dendritic cells (Fig. 7, 9 We conclude that the
aggregates of proliferating dendritic cells have some MLRstimulating activity but that it is the mature released cells
that are fully potent, some 100-300 times more active on
a per cell basis than the populations in the starting culture
at 1-7 d. During days 7-20 of culture, total cell numbers
also expanded at least 5-10-fold.
Homing Activity of Dendritic Cells In Viva A second specialized feature of dendritic cells is their capacity to home to
the T areas of peripheral lymphoid tissues (8, 10). To assess
homing, we injected cells that had been labeled with carboxyftuorescein into the footpads. 1 d later, sections of the
popliteal lymph nodes were stained with mAbs to B cells
or T cells (secondary alkaline phosphatase anti-rat Ig conjugate) followed by peroxidase rabbit antifluorescein antibody.
Blood leukocytes, even when given at a dose of 106 cells
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centage of the cells in the aggregates. The wells were washed
free of radiolabel, and then the aggregates were dislodged
and separated from free cells by 1-g sedimentation. The aggregates were transferred to fresh medium without radiolabel,
and over the next 1-3 d of culture, many dendritic cells were
released into the medium. When the "chased" cultures were
examined, several findings were apparent. The labeling index
remained high, i.e., most of the progeny of cells that were
proliferating in the aggregates were not being lost from the
cultures. Second, the grain counts were diluted severalfold
from those apparent in the original pulse. Third, cells expressing the markers of mature dendritic cells (NLDC-145,
the 2A1 granular antigen, high levels of MHC class II) were
now radiolabeled (Fig. 6, right). Therefore, the cellular aggregates that GM-CSF was inducing in cultured mouse blood
were actively proliferating and releasing nonproliferating
progeny with many of the typical cytologic and antigenic
features of mature dendritic cells, including the 2A1 granular
antigen, the NLDC145 marker, and high levels of MHC
class II.

per footpad, failed to home to the lymphoid organ. When
we tested dendritic cells that had been generated with GMCSF from blood, homing to the T area was observed with
injections of 2 x 105 cells (Fig. 8). The selective localization to the T areas was confirmed by double labeling the specimens with mAbs that stain B cells or T cells (Fig. 8). Therefore, dendritic cells produced in culture have the key functional
features of this lineage: homing to the T-dependent regions
and strong accessory activity.

Requirements for Generating Dendritic Cell Colonies from
Blood. The surface phenotype of the blood cell that gives
rise to the dendritic cell colonies was assessed by treating the
starting population with antibodies and complement. Treatment with either 33D1 anti-dendritic cell, anti-MHC class
II, or anti-Thyol did not eliminate the colony-forming unit
(not shown). Instead, removal of Thy-1 + or Ia + cells enriched colony numbers severalfold. CSFs other than GM-CSF
were also tested, either at the start of the 1-3-wk culture,
or upon transfer of 2-3-wk-old aggregates to form veiled cells
(Fig. 1). None of the CSFs tested (i.e., IL-3, M-CSF, G-CSF,
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or stem cell factor) supported the formation of colonies or
mature dendritic cells. Therefore, the growing dendritic colonies are very much dependent upon GM-CSF.
Discussion

In an effort to identify proliferating precursors to the dendritic cell system, we set up cultures from several tissues that
lacked mature dendritic cells and supplemented these with
different growth factors, particularly the CSFs (M-CSF,
G-CSF, IL-3, GM-CSF, II.,1, and SCF). Neonatal epidermis,
which contains mainly Ia- Langerhans cells (29), was tried
first but to no avail. Bone marrow was tried next, but it was
difficult in bulk cultures to identify typical colonies or large
numbers of dendritic cells. The marrow cultures became overgrown with macrophages. When we turned to blood, which
has few typical dendritic cells in the mouse (30), an entirely
different phenomenon was observed. Growing cell aggregates
appeared after ,,o6 d in culture, and these were often covered
with profiles having the unusual and motile processes of den-
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Figure 8. Homing activity of dendritic cells released from proliferating cell aggregates. The dendritic cells were tagged with carboxyfluorescein
and as a result could be labeled in these cryostat sections with a peroxidase-conjugated anti-FITC antibody plus diaminobenzidine(brown color). The
sections were then double labeled with mAbs to B cells (left; RA3-6B2.1 anti-B220) or T cells (right; 53-6.7 anti-CD8; ATCC TIB 105). Note that
the dendritic cells (brown profiles) homed to the deep cortex of the lymph node, which are the sites containing most of the recirculating T cells as
well as interdigitating cells (top, x43; bottom, x170).

or in sections (thymus cortex, spleen red pulp, lymph node
medulla). In pulse-chase protocols, large numbers of labeled
progeny were released from the aggregates, and these released
cells were nonadherent, motile, and strongly stimulatory in
the MLR. After combined autoradiography and immunoperoxidase labeling, the labeled progeny carried the granular
antigens, the NLDC-145 antigen, and very high levels of MHC
class II. Each of these cytologic and antigenic markers are
largely restricted to dendritic cells.
We believe that maturation to typical nonproliferating dendritic cells occurred within the aggregate. The aggregates
were covered with cells with the sheet-like or veiled processes
of dendritic cells. Cells with markers of mature dendritic cell
markers (high MHC class II, 2Al-positive granules, NLDC
antigen) were also observed at the periphery of the cell aggregates (Fig. 6, left and middle). However, it was difficult
to isolate the aggregate intact, without dislodging these more
mature cells. The mechanism whereby dendritic cells matured
and left the aggregate was not dear. Maturation was enhanced
in older cultures (>2 wk) or by removing adherent stroma
cells. Both proliferation and maturation was blocked if the
cultures contained too many fibroblasts.
The functional maturation that occurred in the proliferating aggregate is striking. The dendritic cells that were generated in culture were potent MLR stimulators. 102 dendritic
cells induced a much stronger primary MLR than 10s blood
leukocytes (Fig. 7). The increase in stimulating activity per
Ia + cell was at least 2 logs between the time that the aggregates first appeared and the time that typical dendritic cells
were released in large numbers. Over this time period, cell
recovery increased 5-10-fold. Also, the dendritic cell progeny
homed in a precise way to the T cell area of lymph node
(Fig. 8), another functional property that was not detectable
in blood cells (data not shown).
Given the criteria that have become evident in this paper,
it will be feasible to look for proliferating progenitors of dendritic cells in other organs. It is known that proliferating
precursors are giving rise to the rapidly turning over populations of dendritic cells in spleen (15) and afferent lymph (16).
The proliferation of leukocytes (other than T cells) occurs
in the bone marrow, but it may be that for dendritic cells,
the marrow also seeds the blood and other tissues with progenitors that then proliferate extensively as shown here. By
being able to prepare the otherwise trace dendritic cell in large
numbers, it should be more feasible to pursue previously unexplored areas of dendritic cell function. Specifically, growing
dendritic cells will facilitate molecular and clinical studies on
the mechanism of action of these APCs, including their capacities to capture and retain antigens in an immunogenic
form (4, 6, 14) and act as adjuvants for the generation of
immunity in vivo (1, 14, 31).

We thank Mrs. Bettina Trokenbacher for valuable technical help, and Judy Adams and Stuart Gezelter
for assistance with the illustrative material.
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dritic cells. With time, typical nonadherent dendritic cells
were released. The latter had the morphology and movement
of dendritic cells as previously described in cultured mouse
spleen, mouse skin, lymph from several species, and human
blood (25-27). Therefore, to identify proliferating dendritic
cells, it seems critical to begin with an appropriate starting
population (in this case, blood) and to supplement the culture with GM-CSF.
We think that the initial aggregates that appeared in the
cultures represented clones, since small groups of four to six
cells were observed early on, e.g., day 5. We tried to prove
that the aggregates were clonal by mixing blood cells from
strains that were distinguished with markers to polymorphic
antigens like CD44 and MHC class II. However, we could
not complete the experiments since we found that mouse
strains differed in the number and speed with which colonies
developed. BALB/c and DBA (and FI strains derived therefrom) were the most active; B6 and B10 were several times
less active; and strains like CBA/J, C3H/He, and A/J were
poor sources of proliferating, dendritic cell aggregates.
The precursors to the aggregates of proliferating dendritic
cells were not typical monocytes or dendritic cells, because
the number of aggregates that developed could be increased
substantially if one depleted monocytes by adherence or Iapositive cells with antibody and complement. We tentatively
conclude that blood contains an Ia- precursor that forms a
proliferating aggregate. In the aggregate, dendritic cells mature and are released as nonproliferating progeny.
The formation of aggregates of dendritic cells required exogenous GM-CSF. If the aggregates were placed in macrophage- or granulocyte-restricted CSFs (M-CSF, G-CSF),
proliferation ceased and neither macrophages nor granulocytes were formed. Because the cultures contained macrophages and some stromal cells, in addition to the dendritic
cell aggregates, it was possible that other cytokines were being
produced that were critical to the formation of dendritic cells.
It appears, however, that the cells in the aggregates have lost
responsiveness to M- and G-CSF, and that dendritic cells represent a distinct myeloid pathway of development. Perhaps
the pathway originates from a common precursor in which
the dendritic cell lineage is an offshoot that no longer responds
to macrophage- and granulocyte-restricted CSFs.
Labeling with [3H]thymidine, using pulse and pulse-chase
protocols, was important in establishing the precursor-product
relationships that were taking place in these liquid cultures
(Fig. 6). In a 2-h pulse, virtually every labeled cell lacked two
typical markers of mature dendritic cells, i.e., the NLDC145 interdigitating cell surface antigen (13) and the recently
identified 2A1/M342 granular cytoplasmic antigens (WitmerPack et al., manuscript in preparation). These mAbs do not
stain most macrophage populations that we have examined
either as isolated cells (blood, spleen, peritoneal macrophages)
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